Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) has issued an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. has outlined the terms of reference for its Nomination Committee, which was established to review and recommend board appointments and ensure compliance with applicable laws and regulations. The committee will consist mainly of independent non-executive directors, and it will meet at least once annually to fulfill its duties, impacting the company’s governance structure and potentially its strategic direction.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$5.30 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands with limited liability, operating within the pharmaceutical industry. The company focuses on developing innovative drugs and therapies, with a particular emphasis on oncology treatments.
Average Trading Volume: 7,710,745
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.87B
See more insights into 1167 stock on TipRanks’ Stock Analysis page.